Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trialAdrian F. Hernandez, Lauren B. Cooper, Karl M. Thorpe et al.|The Lancet|2018Cited by 1.8k
In-Hospital Initiation of Sodium-Glucose Cotransporter-2 Inhibitors for Heart Failure With Reduced Ejection FractionVishal N. Rao, Stephen J. Greene, Evan Murray et al.|Journal of the American College of Cardiology|2021Cited by 93
Medical Management of Heart Failure With Reduced Ejection Fraction in Patients With Advanced Renal DiseaseAaron M. Hein, Robert J. Mentz, Julia J. Scialla et al.|JACC Heart Failure|2019Cited by 59
Framework to Classify Reverse Cardiac Remodeling With Mechanical Circulatory Support: The Utah-Inova StagesPalak Shah, Stavros G. Drakos, Mitchell A. Psotka et al.|Circulation Heart Failure|2021Cited by 50
Torsemide Is Associated with Higher Levels of Urinary Biomarkers of Tubular Injury Compared to FurosemideNaila Ijaz, Christopher R. deFilippi, Lauren B. Cooper et al.|Journal of Cardiac Failure|2020Cited by 1